Donald D. Rao

1.7k total citations
22 papers, 1.1k citations indexed

About

Donald D. Rao is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Donald D. Rao has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Donald D. Rao's work include RNA Interference and Gene Delivery (12 papers), Advanced biosensing and bioanalysis techniques (8 papers) and MicroRNA in disease regulation (5 papers). Donald D. Rao is often cited by papers focused on RNA Interference and Gene Delivery (12 papers), Advanced biosensing and bioanalysis techniques (8 papers) and MicroRNA in disease regulation (5 papers). Donald D. Rao collaborates with scholars based in United States and United Kingdom. Donald D. Rao's co-authors include John Nemunaitis, Neil Senzer, John S. Vorhies, Alice Huang, Zhaohui Wang, James G. Granneman, Kristine N. Lahners, Michele A. Cleary, Robert G. MacKenzie and Padmasini Kumar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Donald D. Rao

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald D. Rao United States 15 803 243 156 118 96 22 1.1k
Scott D. Rose United States 21 1.4k 1.7× 287 1.2× 365 2.3× 101 0.9× 82 0.9× 34 1.8k
Queta Boese United States 7 2.0k 2.5× 468 1.9× 299 1.9× 78 0.7× 95 1.0× 8 2.3k
Todor Dimitrov United States 12 716 0.9× 127 0.5× 247 1.6× 159 1.3× 84 0.9× 21 1.1k
Elen Gócza Hungary 16 1.1k 1.3× 111 0.5× 411 2.6× 64 0.5× 77 0.8× 50 1.5k
Marielle Afanassieff France 16 822 1.0× 84 0.3× 172 1.1× 69 0.6× 86 0.9× 32 1.2k
Hanna P. Lesch Finland 18 940 1.2× 157 0.6× 398 2.6× 148 1.3× 28 0.3× 35 1.3k
Claudio Passananti Italy 25 1.2k 1.6× 111 0.5× 269 1.7× 336 2.8× 87 0.9× 66 1.6k
Zain Paroo United States 18 1.6k 1.9× 745 3.1× 129 0.8× 53 0.4× 47 0.5× 22 1.9k
Christian Pinset France 27 2.1k 2.6× 133 0.5× 374 2.4× 152 1.3× 359 3.7× 67 2.6k
Julia M. Bosher United Kingdom 11 876 1.1× 97 0.4× 227 1.5× 177 1.5× 59 0.6× 11 1.2k

Countries citing papers authored by Donald D. Rao

Since Specialization
Citations

This map shows the geographic impact of Donald D. Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald D. Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald D. Rao more than expected).

Fields of papers citing papers by Donald D. Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald D. Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald D. Rao. The network helps show where Donald D. Rao may publish in the future.

Co-authorship network of co-authors of Donald D. Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Donald D. Rao. A scholar is included among the top collaborators of Donald D. Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald D. Rao. Donald D. Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Donald D., Xiuquan Luo, Zhaohui Wang, et al.. (2018). KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex. PLoS ONE. 13(5). e0193644–e0193644. 10 indexed citations
2.
Manning, Luisa, Minal Barve, Gladice Wallraven, et al.. (2017). Assessment of Low Dose Vigil® Engineered Autologous Tumor Cell (EATC) Immunotherapy in Patients with Advanced Solid Tumors. 2(1). 3 indexed citations
3.
Wang, Zhaohui, et al.. (2016). Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery. Toxicological Sciences. 155(2). 400–408. 7 indexed citations
4.
Rao, Donald D., Zhaohui Wang, Xiuquan Luo, et al.. (2016). Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma. Molecular Therapy. 24(8). 1412–1422. 37 indexed citations
5.
Barve, Minal, Zhaohui Wang, Padmasini Kumar, et al.. (2015). Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer. Molecular Therapy. 23(6). 1123–1130. 14 indexed citations
6.
Rao, Donald D., Zhaohui Wang, Neil Senzer, & John Nemunaitis. (2013). RNA interference and personalized cancer therapy.. PubMed. 15(81). 101–10. 25 indexed citations
7.
Rao, Donald D., Neil Senzer, Zhaohui Wang, et al.. (2012). Bifunctional Short Hairpin RNA (bi-shRNA): Design and Pathway to Clinical Application. Methods in molecular biology. 942. 259–278. 15 indexed citations
8.
Liu, Shi‐He, Donald D. Rao, John Nemunaitis, et al.. (2012). PDX-1 Is a Therapeutic Target for Pancreatic Cancer, Insulinoma and Islet Neoplasia Using a Novel RNA Interference Platform. PLoS ONE. 7(8). e40452–e40452. 25 indexed citations
9.
Nemunaitis, John, Donald D. Rao, Shi‐He Liu, & F. Charles Brunicardi. (2011). Personalized Cancer Approach: Using RNA Interference Technology. World Journal of Surgery. 35(8). 1700–1714. 7 indexed citations
10.
Wang, Zhaohui, Donald D. Rao, Neil Senzer, & John Nemunaitis. (2011). RNA Interference and Cancer Therapy. Pharmaceutical Research. 28(12). 2983–2995. 113 indexed citations
11.
Rao, Donald D., Phillip B. Maples, Neil Senzer, et al.. (2010). Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference. Cancer Gene Therapy. 17(11). 780–791. 36 indexed citations
12.
Rao, Donald D., et al.. (2010). Potential use of RNA interference in cancer therapy. Expert Reviews in Molecular Medicine. 12. e26–e26. 32 indexed citations
13.
Rao, Donald D., Neil Senzer, Michele A. Cleary, & John Nemunaitis. (2009). Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development. Cancer Gene Therapy. 16(11). 807–809. 71 indexed citations
14.
Rao, Donald D., John S. Vorhies, Neil Senzer, & John Nemunaitis. (2009). siRNA vs. shRNA: Similarities and differences. Advanced Drug Delivery Reviews. 61(9). 746–759. 459 indexed citations
15.
Yao, Fayi, Fei Yu, Lijie Gong, et al.. (2004). Microarray analysis of fluoro-gold labeled rat dopamine neurons harvested by laser capture microdissection. Journal of Neuroscience Methods. 143(2). 95–106. 31 indexed citations
16.
Granneman, James G., Kristine N. Lahners, & Donald D. Rao. (1992). Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block.. Molecular Pharmacology. 42(6). 964–970. 79 indexed citations
17.
Rao, Donald D., et al.. (1990). Two forms of the rat D2 dopamine receptor as revealed by the polymerase chain reaction. FEBS Letters. 263(1). 18–22. 39 indexed citations
18.
Rao, Donald D. & Alice Huang. (1982). Interference among defective interfering particles of vesicular stomatitis virus. Journal of Virology. 41(1). 210–221. 39 indexed citations
19.
Rao, Donald D. & Alice Huang. (1980). RNA synthesis of vesicular stomatitis virus. X. Transcription and replication by defective interfering particles. Journal of Virology. 36(3). 756–765. 9 indexed citations
20.
Rao, Donald D. & Alice Huang. (1979). Synthesis of a small RNA in cells coinfected by standard and defective interfering particles of vesicular stomatitis virus.. Proceedings of the National Academy of Sciences. 76(8). 3742–3745. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott D. Rose Breakdown of academic impact, for papers by Queta Boese Breakdown of academic impact, for papers by Todor Dimitrov Breakdown of academic impact, for papers by Elen Gócza Breakdown of academic impact, for papers by Marielle Afanassieff Breakdown of academic impact, for papers by Hanna P. Lesch Breakdown of academic impact, for papers by Claudio Passananti Breakdown of academic impact, for papers by Zain Paroo Breakdown of academic impact, for papers by Christian Pinset Breakdown of academic impact, for papers by Julia M. Bosher
Rankless by CCL
2026